In 2023, Cameron Turtle earned $11.70M in total compensation at Spyre Therapeutics, Inc., including $625.00K salary, $141.00K bonus and $10.93M in stock. Most recently sold 19,500 shares in Dec 2020. Currently holds stock worth $24.53M. 2+ years at the helm of Spyre Therapeutics, Inc..
Compensation History
Annual executive compensation data for Cameron Turtle, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$11.70M
Salary
$625.00K
Bonus
$141.00K
Other
$5.20K
Salary
$625.00KBoard Justification
The compensation philosophy aims to attract and retain key employees for the Company’s continued success and growth, balancing internal and external alignment.
Bonus
$141.00KBoard Justification
Discretionary annual bonus for 2023.
Other Compensation
$5.20KBoard Justification
Matching contributions under the 401(k) plan made during 2023.
Restricted Stock
Board Justification
Shares of restricted common stock that vested in 2023, reflecting the vesting schedule of the stock awards.
Performance Metrics
The performance metrics for determining compensation include the achievement of corporate goals and objectives relevant to the compensation of the CEO.
Cameron Turtle
CEO of Spyre Therapeutics, Inc.
Education
B.S. in Bioengineering from the University of Washington, D.Phil. in Cardiovascular Medicine from the University of Oxford.
Sector of Economy
Healthcare
CEO of Spyre Therapeutics, Inc. for
2 years 2 months (Oct 2023 - Present)
Previous Experience
Venture Partner at Foresite Labs, Chief Strategy Officer of BridgeBio Pharma, Chief Business Officer of Eidos Therapeutics.
Other Spyre Therapeutics, Inc. CEOs
Holdings
Track Cameron Turtle's stock holdings and portfolio value over time.
Total Stock Sold
$3.61M
$3.61M
83,307 BBIO shares
What if they kept their stock?
If Cameron Turtle didn't sell their stock, today they would have:
Extra BBIO83,307 shares worth $6.13M.
This is 69.71% and $2.52M more than what they got when they sold the stock.
Insider Trading
Cameron Turtle's recent stock transactions, purchases, and sales filed with the SEC.
$1.36M
BBIO at $69.64/share
Dec 28, 2020
Sale
$235.58K
BBIO at $47.12/share
Nov 24, 2020
Sale
$105.12K
BBIO at $42.05/share
Nov 5, 2020
Sale
$549.83K
BBIO at $37.92/share
Sep 30, 2020
Sale
$105.02K
BBIO at $42.01/share
Sep 18, 2020
Sale
$92.65K
BBIO at $37.06/share
Sep 15, 2020
Sale
$70.05K
BBIO at $35.02/share
Sep 11, 2020
Sale
2,745 shares
BBIO
Sep 1, 2020
Received
$329.10K
BBIO at $32.91/share
Jun 30, 2020
Sale
$64.03K
BBIO at $32.01/share
Apr 27, 2020
Sale
Rivals
Compare Cameron Turtle with competitor CEOs and industry peers.